NuCana (NCNA) Interest Income - Deposits (2017 - 2025)
NuCana (NCNA) reported Interest Income - Deposits of $244750.6 for Q4 2025, up 161.22% on a YoY basis from $93695.6 in Q4 2024, and up 63.41% sequentially from $149779.2 in Q3 2025.
NuCana (NCNA) Interest Income - Deposits (2017 - 2025) Analysis & Trends
NuCana (NCNA) has 9 years of Interest Income - Deposits data on file, last reported at $244750.6 in Q4 2025.
- For the quarter ending Q4 2025, Interest Income - Deposits rose 161.22% year-over-year to $244750.6; the trailing twelve-month figure through Dec 2025 stood at $593468.7 (up 24.97% YoY), and the FY2025 full-year result was $464115.6, down 2.4% from the prior year.
- Interest Income - Deposits rose to $244750.6 in Q4 2025, from $149779.2 in the prior quarter.
- In the past five years, Interest Income - Deposits ranged from a high of $391394.1 in Q1 2023 to a low of $28950.3 in Q3 2021.
- A 5-year average of $135408.3 and a median of $134214.0 in 2025 frame the typical range for Interest Income - Deposits.
- Across the five-year window, Interest Income - Deposits slumped 86.19% in 2021 and jumped 840.92% in 2023, its largest moves.
- Tracing NCNA's Interest Income - Deposits over 5 years: stood at $29656.2 in 2021, then jumped by 452.03% to $163710.8 in 2022, then advanced by 13.72% to $186172.8 in 2023, then slumped by 49.67% to $93695.6 in 2024, then jumped by 161.22% to $244750.6 in 2025.
- Business Quant data shows NCNA's Interest Income - Deposits at $244750.6 in Q4 2025, $149779.2 in Q3 2025, and $93695.6 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Deposits (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 244,750.58 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 244,750.58 |
| Sep 30, 2025 | 149,779.20 |
| Dec 31, 2024 | 93,695.63 |
| Sep 30, 2024 | 105,243.31 |
| Jun 30, 2024 | 118,648.75 |
| Mar 31, 2024 | 157,296.25 |
| Dec 31, 2023 | 186,172.78 |
| Sep 30, 2023 | 174,802.50 |
| Jun 30, 2023 | 200,218.10 |
| Mar 31, 2023 | 391,394.07 |
| Jun 30, 2022 | 163,710.85 |
| Mar 31, 2022 | 41,596.91 |
| Dec 31, 2021 | 29,656.23 |
| Sep 30, 2021 | 28,950.25 |
| Jun 30, 2021 | 47,522.76 |
| Mar 31, 2021 | 33,094.10 |
| Dec 31, 2020 | 25,088.57 |
| Sep 30, 2020 | 27,100.56 |
| Jun 30, 2020 | 114,235.99 |
| Mar 31, 2020 | 239,708.76 |